 |
Biological Markers - Metabolism
Research News and Information
Definition of 'Biological Markers'Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc. |
Saturday, November 21, 2009
Biomarkers of lung-related diseases: current knowledge by proteomic approaches.
29 Nov 2009 
The lung epithelial surface is one of the vital barriers or sensors in the body responding to the external atmosphere and thereby always subjecting to direct toxicological exposure, stress, stimulus, or infection. Due to its relatively higher ... Read more...
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.
29 Nov 2009 Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults. Despite advances in molecular biology and genetics of cancer there is no currently available treatment for these tumors. Aberrant patterns of ... Read more...
29 Nov 2009 Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults. Despite advances in molecular biology and genetics of gliomas currently there is no effective treatment or promising molecularly targeted ... Read more...
Latest indexed articles for 'Biological Markers - Metabolism'
These are the very latest articles for this heading:
- Biomarkers of lung-related diseases: current knowledge by proteomic approaches. 29 Nov 2009
- Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. 29 Nov 2009
- Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. 29 Nov 2009
- Benign fibroblastic polyps of the colon. 30 Oct 2009
- The cellular and molecular immune response of the weanling piglet to staphylococcal enterotoxin B. 30 Oct 2009
- Thighs and heart disease. Exercise, muscle mass, and insulin sensitivity.
19 Oct 2009 - Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. 13 Oct 2009
- Harnessing immune alterations in neurodegenerative diseases. 13 Oct 2009
- Relationships between biomarkers in aging and dementia. 11 Oct 2009
- Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis. 29 Sep 2009
- Biological effects of high-energy neutrons measured in vivo using a vertebrate model. 29 Sep 2009
- Novel features of boundary cap cells revealed by the analysis of newly identified molecular markers. 29 Sep 2009
- Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. 29 Sep 2009
- Acute coronary syndromes: diagnosis and management, part I. 29 Sep 2009
- Atherosclerosis in survivors of Kawasaki disease. 29 Sep 2009
- Role of cholesterol determination in ascitic fluid analysis. 29 Sep 2009
- A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. 29 Sep 2009
- The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. 29 Sep 2009
- Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea. 29 Sep 2009
- Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. 29 Sep 2009
See a longer list of these articles.
Technical information about 'Biological Markers'
Definition: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Registry Number: 0
Descriptor UI: D015415
Alternative terms: Biological Markers; Markers, Biological; Biomarkers; Marker, Biological; Biological Marker; Biologic Marker; Marker, Biologic; Biologic Markers; Markers, Biologic; Viral Markers; Viral Marker; Marker, Viral; Markers, Viral; Biochemical Marker; Marker, Biochemical; Markers, Biochemical; Biochemical Markers; Surrogate Endpoints; Endpoints, Surrogate; Surrogate End Points; End Points, Surrogate; Surrogate Endpoint; Endpoint, Surrogate; Surrogate End Point; End Point, Surrogate; Markers, Immunologic; Marker, Immunologic; Immunologic Marker; Immunologic Markers; Immune Marker; Marker, Immune; Immune Markers; Markers, Immune; Markers, Laboratory; Laboratory Markers; Marker, Laboratory; Laboratory Marker; Serum Markers; Markers, Serum; Serum Marker; Marker, Serum; Surrogate Markers; Markers, Surrogate; Surrogate Marker; Marker, Surrogate; Markers, Clinical; Clinical Markers; Marker, Clinical; Clinical Marker;
Related Mesh Headings: Molecular Probes;
Allowable Qualifiers: analysis; blood; cerebrospinal fluid; chemistry; metabolism; urine;
Tree Number: D23.101;
History Note: 89
Technical Notes: IM general only; coordinate NIM with specific substance (IM); note that many specific markers are available; DF: BIOL MARKERS